Margit Mahlapuu
Amministratore Delegato presso ScandiCure AB
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Stefan Johnsson | M | 65 |
University of Gothenburg
| - |
| Jonas Göran Ekblom | M | 59 |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | 14 anni |
| Anette Asklin | F | 63 |
University of Gothenburg
| 17 anni |
| Maarten de Château | M | 61 |
Sixera Pharma AB
 Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | 7 anni |
| Torbjörn Egelrud | M | - |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | 11 anni |
| Stig Lennart Hansson | M | 68 |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | 11 anni |
| Nils-Göran Pettersson | M | 79 |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | - |
| Claes Sverker Jern | M | 70 |
University of Gothenburg
| - |
| Mikael Olsson | M | 76 |
University of Gothenburg
| - |
| Carina Thorstensson | F | - |
University of Gothenburg
| - |
| Magnus Wassenius | M | - |
University of Gothenburg
| - |
| Maria Utterhall | F | - |
University of Gothenburg
| - |
| Jan Birger Fredrik Toernell | M | 64 |
University of Gothenburg
| - |
| Jan Holmgren | M | 80 |
University of Gothenburg
| 44 anni |
| Bengt-Åke Lennart Bengtsson | M | 80 |
University of Gothenburg
| - |
| Rob Hellingwerf | M | 70 |
University of Gothenburg
| - |
| Helena Maria Brisby | F | 59 |
University of Gothenburg
| - |
| Tommy Holger Hansson | M | 81 |
University of Gothenburg
| - |
| Stig Jörgen Månsson | M | 66 |
University of Gothenburg
| - |
| Per Lennart Fogelstrand | M | 53 |
University of Gothenburg
| - |
| Ulf Martin Yrlid | M | 53 |
University of Gothenburg
| - |
| Kristian Samuelsson | M | 47 |
University of Gothenburg
| - |
| Margit Alt Murphy | M | - |
University of Gothenburg
| - |
| Per Jesper Dahlberg | M | 60 |
ScandiCure AB
 ScandiCure AB Pharmaceuticals: MajorHealth Technology ScandiCure AB develops anti-diabetic drug based on small molecule antagonists of a novel key mediator. The company was founded by Margit Mahlapuu on August 8, 2016 and is headquartered in Göteborg, Sweden. | - |
| Bo Dahlbom | M | - |
University of Gothenburg
| - |
| Kristina Luthman | M | - |
University of Gothenburg
| - |
| Bo Nils Lennernäs | M | 61 |
University of Gothenburg
| - |
| Arvid M. Carlsson | M | - |
University of Gothenburg
| - |
| Eva Halvarsson | F | 62 |
University of Gothenburg
| - |
| Björn Lennart Dahlöf | M | 71 |
University of Gothenburg
| - |
| Roger William Gunnarsson | M | 77 |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | - |
| Göran Harald Linder | M | 62 |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | - |
| Torsten Rüdiger Goesch | M | 65 |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | - |
| Jan Anders Holgersson | M | - |
University of Gothenburg
| - |
| Claes Martin Strannegård | M | - |
University of Gothenburg
| - |
| Magnus Sjögren | M | 60 |
University of Gothenburg
| 22 anni |
| Kjell Olmarker | M | 66 |
University of Gothenburg
| - |
| Thomas Bengt Eldered | M | 64 |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | - |
| Cecilia Iréne Schelin Seidegård | M | 70 |
University of Gothenburg
| - |
| Jörgen Ekström | M | - |
University of Gothenburg
| - |
| Stefan Hohmann | M | 68 |
University of Gothenburg
| - |
| Nils Lycke | M | 70 |
University of Gothenburg
| - |
| Elisabet Litsmark Nordenstam | F | 76 |
University of Gothenburg
| - |
| Peter Svalander | M | - |
University of Gothenburg
| - |
| Per Nellgård | M | - |
University of Gothenburg
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Carl Johan Kördel | M | 62 |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 anni |
| Mats Gunnar Pettersson | M | 78 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 anni |
| Alf Gunnar Martin Nicklasson | M | 69 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 3 anni |
| Ulf Ljungberg | M | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 3 anni |
| Björn Westberg | M | 62 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 2 anni |
| Terje Kalland | M | 73 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 3 anni |
| Viktor Drvota | M | 59 |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | 3 anni |
| Paul de Potocki | M | 62 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 5 anni |
| Gregory S. Shotzberger | M | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 4 anni |
| Sven Håkan Björklund | M | 68 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 anni |
| Hans Arwidsson | M | 66 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 17 anni |
| Charlotta Ljungqvist | M | 63 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 anni |
| Tim Watts | M | 66 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 5 anni |
| Pekka Ilmari Lettijeff | M | 63 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 1 anni |
| Jan Hermansson | M | 68 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 9 anni |
| Kerstin Hasselgren | F | 63 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Svezia | 61 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Margit Mahlapuu
- Contatti personali
